A Map of β-cell Differentiation Pathways supports Stem Cell Therapies for Diabetes

Posted on 2 June 2019

The pancreas is home to the Islets of Langerhans, biological structures that contain insuling producing beta-cells. Destruction of these beta-cells, either by the immune system, or during aging, leads to Type 1, or Type 2 diabetes, respectively.

One potential technique for treating diabetes is creating beta-cells from stem cells to transplant into patients.

A recent study, published in Nature, has begun to map the molecular steps in the differentiation of stem cells into islet-like cells. These steps were observed via high resolution, transcriptional profiling of over 100,000 human cells undergoing β-cell differentiation, and this has taken us closer to understanding the pathways involved in the generation of stem-cell-derived beta-cells.

Differentiation of human pancreatic islet cells in vitro.

This is an important advance in the research behind stem-cell based diabetes therapies.


  1. Veres, A., Faust, A.L., Bushnell, H.L. et al. Charting cellular identity during human in vitro β-cell differentiation. Nature 569, 368–373 (2019). https://doi.org/10.1038/s41586-019-1168-5
Featured in This Post

Never Miss a Breakthrough!

Sign up for our newletter and get the latest breakthroughs direct to your inbox.

Checkout the Gowing Life Store

Scientifically Developed Blended Vitamins, and Exclusive Supplements For Health, and Longevity

Copyright © Gowing Life Limited, 2022 • All rights reserved • Registered in England & Wales No. 11774353 • Registered office: Ivy Business Centre, Crown Street, Manchester, M35 9BG.